Serial #79282641
LIVE

Serial Number

79282641

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79282641 Trademark

Serial Number: 79282641 • Registration: 6155900

Serial #79282641 is a trademark filed by NOVARTIS AG on February 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 10, 2020

Registration Date

September 22, 2020

Published for Opposition

July 7, 2020

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; ] pharmaceutical preparations for the [ prevention and ] treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 23, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 23, 2026 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 12, 2026 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Feb 10, 2026 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 9, 2026 APRE
TEAS SECTION 71 RECEIVED
Oct 3, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2021 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Jan 15, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 15, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2020 CNSA
REFUSAL PROCESSED BY IB
May 29, 2020 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 19, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 19, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 19, 2020 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 14, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 9, 2020 REPR